Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Patry

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Bulletin Du Cancer|March 1, 1996
[Vaccination with genetically modified IL-2 secreting cells in a rat model of colonic carcinoma]Y Patry, K Meflah, J Le Pendu
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1995
Co-segregation of tumor immunogenicity with expression of inducible but not constitutive hsp70 in rat colon carcinomasA Ménoret, Y Patry, C Burg, et al.
Gastroenterology|November 1, 1995
Immunization against a rat colon carcinoma by sodium butyrate-treated cells but not by interleukin 2-secreting cellsY Patry, J Y Douillard, K Meflah, et al.
Gut|December 15, 2000
Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in ratsP Perrin, F Pierre, Y Patry, et al.
Cytokine|November 1, 1995
Leukaemia Inhibitory Factor derived from rat colon carcinoma cells increases host susceptibility to tumour growthC Burg, Y Patry, J Le Pendu, et al.
Gastroenterology|December 1, 1994
An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosisP Perrin, E Cassagnau, C Burg, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|March 1, 1996
[Vaccination with genetically modified IL-2 secreting cells in a rat model of colonic carcinoma]Y Patry, K Meflah, J Le Pendu
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1995
Co-segregation of tumor immunogenicity with expression of inducible but not constitutive hsp70 in rat colon carcinomasA Ménoret, Y Patry, C Burg, et al.
Gastroenterology|November 1, 1995
Immunization against a rat colon carcinoma by sodium butyrate-treated cells but not by interleukin 2-secreting cellsY Patry, J Y Douillard, K Meflah, et al.
Gut|December 15, 2000
Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in ratsP Perrin, F Pierre, Y Patry, et al.
Cytokine|November 1, 1995
Leukaemia Inhibitory Factor derived from rat colon carcinoma cells increases host susceptibility to tumour growthC Burg, Y Patry, J Le Pendu, et al.
Gastroenterology|December 1, 1994
An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosisP Perrin, E Cassagnau, C Burg, et al.
Pageof 1